Analysis file of drug-induced lung injury : expert opinion for analysis of big data

Analysis file of drug-induced lung injury : expert opinion for analysis of big data

Author
Akihiko Gemma
Publication Year
2024
Publisher
Springer
Language
English
Document Type
Book
Faculty / Subject Heading
Medical Science

Describes the pathologic conditions of drug-induced lung injuries, monitoring strategies, and guides on how to interpret the evidence. It also dives into particular drugs that caused the disorder, such as EGFR inhibitors, anti-EGFR antibodies, mTOR inhibitors, proteasome inhibitors, immune checkpoint inhibitors, neoangiogenesis inhibitors, and other molecular targeted drugs. It outlines the analysis and interpretation of the post-marketing survey on surveillance of each drug for inducing pulmonary lesions presenting diffuse haziness. The data and analysis from this survey are valuable since a guideline is yet to be established due to limited clinical evidence and cases. As new drugs are developed, establishing treatment and event management is crucial.


Keywords: Pharmacology / Toxicology / Lung - Diseases / Drugs - Side effects / Lungs - Wounds and injuries / Médicaments Effets secondaires / Poumons Maladies / Lung Diseases / Lung disorder / Drug-induced / Risk factor / Pathologic conditions / Drug induced interstitial lung disease / Anti-tumor agents / Big data / Pneumology / Respiratory System, Medicine / Public Health - General / Biomedicine - General / Oncology